There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Psoriasis is a chronic inflammatory skin disease, which requires long-term, safe and
effective treatment. Apremilast, a small-molecule PDE4 inhibitor, has been introduced
as psoriasis (and psoriatic arthritis) treatment in Europe in 2015.